Postoperative radiotherapy in periampullary cancers: A brief review

被引：1

作者：

Bahl A. ^{[1
,2
]}

Bhattacharyya T. ^{[1
]}

Kapoor R. ^{[1
]}

Singh O.A. ^{[1
]}

Parsee T. ^{[1
]}

Sharma S.C. ^{[1
]}

机构：

[1] Department of Radiation Oncology, Post-Graduate Institute of Medical Education and Research (PGIMER)

[2] Regional Cancer Center, Post-Graduate Institute of Medical Education and Research (PGIMER)

来源：

Journal of Gastrointestinal Cancer | 2013年 / 44卷 / 1期

关键词：

Periampullary cancers; Radiotherapy; Treatment;

D O I：

10.1007/s12029-012-9421-2

中图分类号：

学科分类号：

摘要：

Background: The treatment of periampullary cancers is complex and challenging. Adjuvant therapy for resected periampullary and pancreatic cancers has been the subject of intense clinical investigations for several decades. Periampullary cancer management has often been clubbed with pancreatic cancers. Discussion: Following surgery, adjuvant chemoradiotherapy has been widely accepted as standard of care in the USA, although different prospective and retrospective studies have shown conflicting results. Controversy regarding the effectiveness of chemoradiotherapy exists in the literature, both in terms of survival as well as toxicity. However, conventional postoperative radiotherapy practice needs to be reviewed in view of changes and developments in radiation techniques in the last decade. In this article, we review the management of periampullary cancers with special emphasis on the adjuvant postoperative radiotherapy. © 2012 Springer Science+Business Media, LLC.

引用

页码：111 / 114

页数：3

共 26 条

[1]

Offerhaus G.J., Giardiello F.M., Krush A.J., Booker S.V., Tersmette A.C., Kelley N.C., Et al., The risk of upper gastrointestinal cancer in familial adenomatous polyposis, Gastroenterology, 102, pp. 1980-1982, (1992)

[2]

Jagelman D.G., Decosse J.J., Bussey H.J., Upper gastrointestinal cancer in familial adenomatous polyposis, Lancet, 1, pp. 1149-1151, (1988)

[3]

Jemal A., Siegal R., Ward E., Hao Y., Xu J., Thun M.J., Cancer statistics 2009, CA Cancer J Clin, 59, pp. 225-249, (2009)

[4]

Kim K., Chie E.K., Jang J.Y., Kim S.W., Han S.W., Oh D.Y., Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma, Clin Transl Oncol, 14, pp. 391-395, (2012)

[5]

Crist D.W., Cameron J.L., The current status of the Whipple operation for periampullary carcinoma, Adv Surg, 25, pp. 21-49, (1992)

[6]

Chakravarthy A., Abrams R.A., Yeo C.J., Korman L.T., Donehower R.C., Hruban R.H., Et al., Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: Acceptable toxicity and suggestion of improved 1 year disease free survival, Int J Radiat Oncol Biol Phys, 48, pp. 1089-1096, (2000)

[7]

Trede M., The surgical treatment of pancreatic carcinoma, Surgery, 97, pp. 28-35, (1985)

[8]

Yeo C.J., Cameron J.L., Sohn T.A., Lillemoe K.D., Pitt H.A., Talamini M.A., Et al., Six hundred fifty consecutive pancraeticoduodenectomies in the 1990s: Pathology, complications and outcomes, Ann Surg, 226, pp. 248-257, (1997)

[9]

Yeo C.J., Cameron J.L., Lillemoe K.D., Sitzmann J.V., Hruban R.H., Goodman S.N., Et al., Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients, Ann Surg, 221, pp. 721-733, (1995)

[10]

Bluemke D.A., Abrams R.A., Yeo C.J., Cameron J.L., Fishman E.K., Recurrent pancreatic adenocarcinoma: Spiral CT evaluation following the Whipple procedure, Radiographics, 17, pp. 303-313, (1997)

← 1 2 3 →